NCT00177268 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
| NCT ID | NCT00177268 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Cutaneous T-cell Lymphoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2004-10 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2004-10 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Eligibility Criteria
Inclusion Criteria: * 18 or older * able and willing to provide informed consent * diagnosed with CTCL * diagnosed with either atopic dermatitis or eczema Exclusion Criteria: * Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Contact & Investigator
Oleg E Akilov, M.D., PhD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT00177268 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cutaneous T-cell Lymphoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00177268 currently recruiting?
Yes, NCT00177268 is actively recruiting participants. Contact the research team at ruhlcl@upmc.edu for enrollment information.
Where is the NCT00177268 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT00177268 clinical trial?
NCT00177268 is sponsored by University of Pittsburgh. The principal investigator is Oleg E Akilov, M.D., PhD at University of Pittsburgh. The trial plans to enroll 200 participants.